"We are proud of the leadership position we have established for these vaccines. Our research and development agreement with Heska Des Moines is the cornerstone of our commitment to maintain the preeminence of these vaccines in the marketplace," commented Steve Schram, AgriLabs' President and CEO. "We are pleased Heska Des Moines has agreed to fund a portion of this effort. We view this as another installment in a long history of mutually beneficial agreements between our companies."
About Heska
Heska Corporation (Nasdaq: HSKA) sells advanced veterinary diagnostic and other specialty veterinary products. Heska's state-of-the-art offerings to its customers include diagnostic instruments and supplies as well as single use, point-of-care tests, vaccines and pharmaceuticals. The company's core focus is on the canine and feline markets where it strives to provide high value products and unparalleled customer support to veterinarians. For further information on Heska and its products, visit the company's website at http://www.heska.com.
About AgriLabs
AgriLabs is the largest private label marketer of veterinary vaccines
and pharmaceuticals in the United States. AgriLabs is proficient in sales,
marketing and technology transfer of current and future compounds or
antigens for both food and companion animal markets. The AgriLabs
distribution network of distribution owners is the largest in the United
States and has the ability to efficiently reach the livestock and consumer
marketplace through various veterinary, direct and retail channels. For
additional information on AgriLabs and its products or distributors, visit
the company website at '/>"/>
| SOURCE Heska Corporation Copyright©2007 PR Newswire. All rights reserved |